Director of API retires

By Dylan Bushell-Embling
Thursday, 10 July, 2008

A director of Australian Pharmaceutical Industries [ASX: API], Barry Frost, announced his retirement today.

Frost has served on the company's board since 1993, and has been deputy chairman since 2001. His resignation will be effective July 31.

API, which markets and distributes prescription and over-the-counter medications, has announced that it is currently looking for replacement for the position.

Australian CDC issues update in wake of Ebola outbreak

After the WHO determined the outbreak of Ebola in the DRC and Uganda to be a public health...

Australia announces $7.2m diphtheria outbreak response package

To respond to the biggest diphtheria outbreak on record, support has been announced for the NT...

MV Hondius passengers return to Australia under strict infection control measures

The Australian CDC has provided an update on hantavirus risk to Australians and infection...

Content from other channels on our network

Outdated, overused and ineffective — time to end mandatory double-checking?

New Support at Home consumer protection measures announced

Chemical-free cleaning: the future of infection control in health care

Latrobe Regional Health charged after nurse "seriously assaulted" by patient

Charges laid following patient death at The Royal Melbourne Hospital

Retread tyre industry under threat: report

Aussie founder reduces need for plastic pallet wrap

CSIRO job cuts cause industry concern

Rittal RiLineX — A standardised 60 mm busbar platform engineered for AS/NZS 61439 switchboards

Renewable energy tender to power a third of NSW homes

Corvus Technology opens Victorian manufacturing facility

NSW announces largest ever boost to renewable power

Arafura Rare Earths to ramp up rare earths mining in NT

AMCRC announces additive manufacturing research investment

PsiQuantum announces Australian site at Moreton Bay Central